Compliance

Back to Antitrust, Competition & Trade

We provide day-to-day advice in all competition law matters to help clients avoid any conflicts with competition laws. We advise clients on the set-up and continuous improvement of compliance programmes. We frequently provide up-to date and tailored compliance training sessions to our client’s employees or law departments (train the trainers).

We also conduct internal investigations and audits, wherever and whenever necessary and with the help of our own CMS Evidence team of forensic experts and market-leading software, Brainspace. The breadth of our international footprint allows us to conduct internal investigations on a national and international level efficiently and effectively.

By working with CMS, clients can be better prepared for potential dawn raids, comply with antitrust/competition laws and ultimately avoid, or in the worst case, reduce fines. Our pioneering proprietary CMS Dawn Raid App provides first-hand advice in case of an emergency. Our exceptionally wide geographic footprint allows us to offer a one-stop-shop support by experienced competition experts for dawn raids (CMS Dawn Raid Network).


Feed

06/02/2024
CMS advises Bruker on the agreement to acquire Chemspeed
Bruker Corporation, a NASDAQ-listed US tech company, entered into a definitive agreement for the acquisition of Chemspeed Technologies AG, a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research for cleantech and consumer applications. The Chemspeed acquisition accelerates Bruker’s entry into lab automation, digitalisation and scientific software solutions. Chemspeed offers modular automation to enhance productivity in R&D and QC departments to achieve more in less time and without additional staff. Chemspeed complements Bruker’s vendor-agnostic plat­form SciY™ for software automation and digital transformation of R&D labs in the life science, biopharma and cleantech industries. An international CMS team headed by Stefan Brunnschweiler and Andrea Relly (Switzerland), in collaboration with the US law firm Nixon Peabody LLP advised Bruker on all legal aspects of the transaction. CMS Switzer­land­Stefan Brunnschweiler, Lead Partner, Corporate / M&AAndrea Relly, Counsel, Corporate / M&ASamuel Gang, Senior Associate, Corporate / M&AAnna Mast, Associate, Corporate / M&AMarquard Christen, Partner, Competition and ComplianceJulia Haas, Senior Associate, Competition and Com­pli­ance­Bernhard Lötscher, Partner, ComplianceSophie Weber, Associate, ComplianceDr Dirk Spacek, Partner, Intellectual PropertyDr Simone Brauch­bar-Birkhäuser, Partner, Intellectual PropertyOlivia Zingg, Associate, Intellectual PropertyMark Cagienard, Partner, TaxJens Lehmann, Senior Associate, TaxMiryam Meile, Senior Associate, Em­ploy­mentSibylle Schnyder, Partner, Real EstateReto Hunsperger, Partner, Com­mer­cialAl­ex­an­der Salamon, Attorney Trainee, Corporate / M&ASophia Rovelli, Attorney Trainee, Corporate / M&AElisabeth Suter, Attorney Trainee, ComplianceCMS BelgiumKai Neuhaus, Partner, Brussel, CompetitionDavid Rappenglück, Associate, Brussel, CompetitionCMS UKRussel Hoare, Partner, Lon­don, Com­pet­i­tion­Claire Barraclough, Associate, Competition